The Bioprocessing Market continues to experience transformative growth driven by rising demand for biologics, advancements in biomanufacturing technologies, and expanding applications across pharmaceuticals, biotechnology, and cell & gene therapy. According to the latest industry projections, the bioprocessing market size is expected to increase from US$ 25.35 billion in 2023 to US$ 72.55 billion by 2031, growing at a robust CAGR of 14.0% during 2023–2031. As global healthcare systems evolve and precision biologics become essential for advanced therapies, bioprocessing stands at the center of innovation, efficiency, and scalable production.

Market Overview

Bioprocessing technologies play a critical role in the development and manufacturing of biologically derived products, including monoclonal antibodies, vaccines, therapeutic proteins, and cell- and gene-based treatments. The growing prevalence of chronic diseases, rising adoption of personalized medicine, and ongoing expansion of biopharmaceutical R&D investments are collectively shaping the positive trajectory of the Bioprocessing Market.

Companies are increasingly shifting toward automated, flexible, and scalable bioprocessing platforms that allow faster production cycles and reduced operational costs. Innovations such as single-use technologies, advanced bioreactors, and fully integrated continuous bioprocessing systems are transforming traditional workflows and enabling faster time-to-market for life-saving therapies.

Download Sample Report @ https://www.theinsightpartners.com/sample/TIPRE00039016

Segmentation Analysis

By Product

Instruments

Consumables and Accessories

By Scale Of Operation

Commercial Operations

Clinical Operations

By Process

Downstream Bioprocess

Upstream Bioprocess

By Application

Monoclonal Antibodies

Vaccines

Recombinant Protein

Cell and Gene Therapy

Analyst Perspective:

The report includes growth prospects owing to the current bioprocessing market trends and their foreseeable impact during the forecast period. The growing cases of chronic diseases are one of the major factors increasing the demand for new drugs, which creates a need for bioprocessing. In addition, personalized treatment of diseases such as cancer increases the demand for various bioprocessing technologies, including cell therapy. The importance of research and development in the life sciences industry has been greatly promoted in recent years. Due to this trend, government support for the pharmaceutical and biotech industries is also increasing. Additionally, a growing focus on preventative measures and alternative medicines for specific applications drives the market for bioprocessing. Additionally, increasing investment in new technologies to overcome performance and quality issues associated with manufacturing bioprocess products is expected to drive bioprocessing market growth.

Market Leaders and Key Company Profiles

• Getinge AB,
• Thermo Fisher Scientific Inc,
• Sartorius AG,
• Corning Inc,
• Bio-Rad Laboratories Inc.
• Merck KGaA,
• 3M Co,
• Eppendorf SE,
• Repligen Corp,
• Entegris Inc,

Market Driver

Increasing Prevalence of Chronic Diseases Propel Market Growth

The sedentary life of older people has boosted the prevalence of lifestyle disorders, such as obesity and diabetes. Inherited genes can also express these conditions along with other health concerns such as cardiovascular disease (CVDs), Alzheimer’s disease, and depression. As per the National Council on Aging, Inc., 80% of adults (aged 65 and more) are reported to suffer from at least one chronic condition in their lifetime. According to the Centers for Disease Control and Prevention (CDC), approximately 6 of 10 people in the US suffered from at least one serious disease, and 4 of 10 people had two or more chronic conditions in 2020.

CVDs, such as angina pectoris, atherosclerosis, and acute myocardial infarction caused because of hectic lifestyles, are among the significant causes of mortality across the world. As per the World Heart Foundation, mortality caused due to CVD has surged by 60% over the past 30 years (1990–2020). 20.5 million deaths were recorded in 2021 due to CVDs. Diabetes is one of the life-threatening chronic diseases with no functional cure. According to the International Diabetes Federation, the number of diabetic cases in North America is anticipated to grow from 46 million in 2017 to 62 million by 2045. As per the Global Cancer Observatory (GLOBOCAN) estimates published in 2020, 19.3 million cancer cases were reported across the world. The number of cases was significantly high in the US, China, and India. The GLOBOCAN further estimates that cancer cases in India would reach ~2.08 million by 2040, representing a rise of 57.5% from 2020. Similarly, as per the World Health Organization data published in February 2022, ~10 million people across the world have succumbed to death due to cancer. An upsurge in the incidence of cancer indicates the need for innovative cancer treatments. Monoclonal antibodies represent a promising class of targeted anticancer agents that enhance the natural ability of immune systems to suppress cancer cell activity and eliminate cancer cells. Antibody–drug conjugates (ADCs) have also shown promising results in cancer treatment.

Conclusion

The Bioprocessing Market is poised for exceptional growth through 2031 as technological innovations, rising biologics production, and expanding therapeutic pipelines continue to reshape the global biomanufacturing landscape. With strong market value prospects and increasing adoption of high-performance bioprocessing solutions, the sector remains essential to the future of advanced therapeutics, precision medicine, and global healthcare resilience.

Related Reports:

Biostimulants Market - https://www.theinsightpartners.com/reports/biostimulants-market

Biopsy Devices Market - https://www.theinsightpartners.com/reports/biopsy-devices-market

Biorationals Market - https://www.theinsightpartners.com/reports/biorationals-market

Bioproduction Market - https://www.theinsightpartners.com/reports/bioproduction-market

About Us:

The Insight Partners is a one-stop industry research provider of actionable intelligence. We help our clients get solutions to their research requirements through our syndicated and consulting research services. We specialize in semiconductor and electronics, aerospace and defense, automotive and transportation, biotechnology, healthcare IT, manufacturing and construction, medical devices, technology, media and telecommunications, and chemicals and materials.

Contact Us:

• If you have any queries about this report or if you would like further information, please get in touch with us:
• Contact Person: Ankit Mathur
• E-mail: ankit.mathur@theinsightpartners.com
• Phone: +1-646-491-9876
• Also Available in: Korean German Japanese French Chinese Italian Spanish